J Korean Rheum Assoc.
2002 Mar;9(1):63-67.
A Case of Malignant Lymphoma during Treatment with Methotrexate for Rheumatoid Arthritis
- Affiliations
-
- 1Department of Internal Medicine, Catholic University of Daegu, School of Medicine, Daegu, Korea.
- 2Department of Pathology, Catholic University of Daegu, School of Medicine, Daegu, Korea.
Abstract
- Rheumatoid arthritis (RA)is a multisystemic inflammatory disease with a prevalance of approximately 1%of the population.The use of disease modifying anti-rheumatic drug (DMARD)is an essential regimen for the treatment of RA. Among DMARDs,methotrexate (MTX)is used worldwide with confirmed effectiveness.However,cytopenia,pulmonary injury,and hepatic toxicity are a few side effects limiting its use.In addition,although the oncogenic potential of MTX is low,several cases have been reported.Recently an increased risk of developing lymphoproliferative disorders has been reported in patients with RA. The incidence is higher in elderly individuals with severe longstanding seropositive RA,those with Sjogren's or Felty's syndrome,and in patients with RA treated with prolonged low dose MTX.We describe a case of RA who developed non-Hodgkin's lymphoma during low dose MTX therapy.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Hyperpigmentation Probably Induced by Methotrexate in a Patient with Rheumatoid Arthritis
- Combination treatment with ldflunomide and methotrexate in patients with rheumatoid arthritis: the efficacy, safety, and predisposing factors for treatment response
- A Case of Diffuse Large B-cell Lymphoma with Liver Involvement in a 67-Year-Old Woman Given Methotrexate for Rheumatoid Arthritis
- Folic acid metabolism and the side effect of the methotrexate in rheumatoid arthritis
- A Case of Methotrexate: Associated Interstitial Pneumonitis in Rheumatoid Arthritis
